ResearcherSun Yat-sen UniversityNo recent work listed

Jian M. Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1749-6789; OpenAlex author ID A5078346658. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 2

PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer. Last author DOI 10.1038/s12276-020-0390-4 ↗
TGF-β in pancreatic cancer initiation and progression: two sides of the same coin. Co-author DOI 10.1186/s13578-017-0168-0 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenbin Li · 1 shared paper, 2020 · strength 0.12
- Paper PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer. DOI 10.1038/s12276-020-0390-4 ↗
Wei Shen · 1 shared paper, 2017 · strength 0.08
- Paper TGF-β in pancreatic cancer initiation and progression: two sides of the same coin. DOI 10.1186/s13578-017-0168-0 ↗
Zhiqiang Tian · 1 shared paper, 2017 · strength 0.08
- Paper TGF-β in pancreatic cancer initiation and progression: two sides of the same coin. DOI 10.1186/s13578-017-0168-0 ↗
Yu Zhang · 1 shared paper, 2017 · strength 0.08
- Paper TGF-β in pancreatic cancer initiation and progression: two sides of the same coin. DOI 10.1186/s13578-017-0168-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.